TY - JOUR T1 - Responses of Acetylcholinesterase from <em>Torpedo marmorata</em> to Salts and Curarizing Drugs JF - Molecular Pharmacology JO - Mol Pharmacol SP - 369 LP - 392 VL - 2 IS - 5 AU - JEAN-PIERRE CHANGEUX Y1 - 1966/09/01 UR - http://molpharm.aspetjournals.org/content/2/5/369.abstract N2 - The structure and catalytic activity of acetylcholinesterase (Acetylcholine acetyl-hydrolase, EC 3.1.1.7) (AChE) from Torpedo marmorata depend upon the ionic strength, Γ/2, of the environment. The sedimentation coefficient of the enzyme is 14 S at Γ/2 = 0.3, but is polydisperse in the range of 10-80 S at Γ/2 = 0.003. The optimal velocity of the reaction catalyzed by AChE increases with ionic strength, while under the same conditions the affinity for the substrate and for several reversible competitive inhibitors decreases. The relative decrease of affinity as a consequence of increased ionic strength is higher for inhibitor molecules containing two quaternary ammonium ions than for compounds containing a single quaternary ammonium group. Among the monoquaternary inhibitors, this decrease is greater for phenyltrimethylammonium than for its 3-hydroxy analog. In solutions of low salt concentration (Γ/2 = 0.003) significant affinity of the enzyme for two pachycurares, flaxedil and d-tubocurarine, can be demonstrated. Both compounds produce partial inhibition of AChE activity, antagonize its inhibition by reversible competitive inhibitors including some leptocurares, and enhance the inhibition by 3-hydroxyphenyltrimethylammonium. By measuring the degree of protection of AChE against thermal inactivation, the dissociation constant for the flaxedil-enzyme complex can be estimated to be about 3 x 10-7 M. These observations and their possible physiological significance are interpreted in terms of conformational alterations of the AChE molecule in response to the binding of the pharmacologic agents. ACKNOWLEDGMENTS The author is greatly indebted to Dr. France Tazieff-Depierre for her contributions to the early stages of this research and gifts of most of the pharmacologic agents and to Mrs. Merry Rubin for her extensive assistance in the preparation of the manuscript. He thanks Drs. P. Ascher, R. Couteaux, J. C. Gerhart, and J. Monod for their comments and suggestions after reading the manuscript. This investigation was supported in part by grants from the National Institutes of Health, National Science Foundation, Jane Coffin Childs Memorial Fund, Délégation Générale à la Recherche Scientifique et Technique, and U.S. Public Health Service research grant GM 12159 from the National Institutes of General Medical Sciences. A portion of the research was carried out during tenure of an Eleanor Roosevelt International Cancer Fellowship administered by the International Union Against Cancer. ER -